Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AU-007 |
Trade Name | |
Synonyms | AU 007|AU007 |
Drug Descriptions |
AU-007 is an antibody that binds to IL-2 and prevents binding to CD25, potentially leading to activation of immune effector cells, decreased expansion of T-regulatory cells, and inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2021;9). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187110 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + AU-007 | AU-007 Aldesleukin | 0 | 1 |
AU-007 | AU-007 | 0 | 1 |